| All | ≤ 64 years | 65–74 years | ≥ 75 years | P | Risk Classification | P | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low risk | Intermediate risk | High risk | Regional/metastatic | Unknown | |||||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | |||
452 | 100.0 | 183 | 40.5 | 178 | 39.4 | 91 | 20.1 | 69 | 17.9 | 140 | 36.4 | 123 | 31.9 | 53 | 13.8 | 67 | |||
Treatment |  |  |  |  |  |  |  |  | < 0.0001 |  |  |  |  |  |  |  |  |  | < 0.0001 |
Surgery only | 104 | 23.0 | 46 | 25.1 | 51 | 28.6 | 7 | 7.7 | Â | 19 | 27.5 | 43 | 30.7 | 24 | 19.5 | 2 | 3.8 | 16 | Â |
 Radical prostatectomy | 93 | 89.4 | 42 | 91.3 | 47 | 92.2 | 4 | 57.1 |  | 17 | 89.5 | 42 | 97.7 | 23 | 95.8 | 2 | 100 | 9 |  |
 Transurethral resection | 11 | 10.6 | 4 | 8.7 | 4 | 7.8 | 3 | 42.9 |  | 2 | 10.5 | 1 | 2.3 | 1 | 4.2 | 0 | 0 | 7 |  |
External radiotherapy | 26 | 5.7 | 6 | 3.3 | 11 | 6.2 | 9 | 9.9 | Â | 10 | 14.5 | 9 | 6.4 | 5 | 4.1 | 1 | 1.9 | 1 | Â |
Brachytherapy | 45 | 10.0 | 34 | 18.6 | 8 | 4.5 | 3 | 3.3 |  | 27 | 39.1 | 16 | 11.4 | 0 | – | 0 | – | 2 |  |
Androgen deprivation only | 34 | 7.5 | 7 | 3.8 | 9 | 5.1 | 18 | 19.8 |  | 0 | – | 3 | 2.1 | 8 | 6.5 | 18 | 33.9 | 5 |  |
Combination therapya | 164 | 36.3 | 52 | 28.4 | 72 | 40.4 | 40 | 43.9 | Â | 4 | 5.9 | 44 | 31.5 | 75 | 61.0 | 30 | 56.6 | 11 | Â |
No treatment / watchful waiting/ Active surveillance | 79 | 17.5 | 38 | 20.8 | 27 | 15.2 | 14 | 15.4 | Â | 9 | 13.0 | 25 | 17.9 | 11 | 8.9 | 2 | 3.8 | 32 | Â |